Alexandria Real Estate Equities Finalizes Major Asset Sale
Alexandria Real Estate Equities, Inc. (NYSE: ARE), a prominent player in the life science real estate industry, has successfully completed a significant strategic sale of the property at 1165 Eastlake Avenue East. Known for developing collaborative mega campuses in areas rich in innovation, the company has sold this fully leased facility, encompassing 100,086 square feet, for an impressive $150 million.
Transaction Details
This important sale was finalized with the long-term tenant, Fred Hutch Cancer Center. The building, which Alexandria developed and delivered in 2021, was sold with a strong capitalization rate of 4.9%, reflecting solid financial performance based on its net operating income for the second quarter of 2024.
Strategic Partnership Through Joint Venture
As part of the asset sale, Alexandria has formed a strategic joint venture with Fred Hutch Cancer Center involving two additional properties located at 1201 and 1208 Eastlake Avenue East. This partnership, covering a total of 206,031 RSF, enhances their long-term collaboration aimed at advancing cancer research and treatment. Alexandria retains a 30% interest in these properties.
Commitment to Advancing Life Science
The recent lease renewals executed by Fred Hutch at these locations, including a notable 15-year extension at 1201 Eastlake, reinforce both parties' commitment to the South Lake Union area. This dedication will enhance Fred Hutch’s operational capacity as it aims to innovate in the treatment of cancer and infectious diseases.
Reinvestment Strategy for Future Growth
The proceeds from this transaction will be strategically reinvested back into Alexandria’s extensive development pipeline. This pipeline includes various active construction projects projected to generate significant annual net operating income—an estimated total of $480 million by the first quarter of 2028 from 5.3 million square feet of Class A/A+ properties currently in development.
About Alexandria Real Estate Equities, Inc.
Founded in 1994, Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a best-in-class REIT dedicated to life sciences, with a strong focus on creating sustainable, collaborative environments for innovation. Their extensive portfolio encompasses major life science hubs across North America. With a market capitalization of $32.5 billion and 42.1 million RSF of operating properties, Alexandria is in a prime position to assist its tenants in attracting top talent and boosting productivity.
Innovative Solutions for Life Science Enterprises
Beyond providing space, Alexandria delivers a vibrant ecosystem for life science companies to thrive. By promoting collaboration and offering strategic capital through its venture platform, Alexandria significantly enhances the prospects of success for its tenants, underscoring its commitment to positively impacting health and innovation.
Frequently Asked Questions
What makes the sale of 1165 Eastlake Avenue East significant?
This sale is a strategic step for Alexandria, allowing them to reinvest in future growth while reinforcing their partnership with Fred Hutch Cancer Center.
Who purchased the property?
Fred Hutch Cancer Center, a long-time tenant, made the purchase as part of their ongoing efforts in cancer research and facility expansion.
What will Alexandria do with the money from this sale?
The proceeds are set to be reinvested into Alexandria's development pipeline, which encompasses several projects aimed at strengthening their portfolio within the life sciences sector.
How long has Alexandria been active in the life science real estate field?
Since its inception in 1994, Alexandria has been a leader in the life science real estate market, consistently expanding its influence in key innovation hubs.
What is the core business model of Alexandria?
Alexandria specializes in creating collaborative mega campuses that foster dynamic environments for life science companies, ensuring high-caliber tenants and sustainable growth.
